CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...